PROMETHAZINE HYDROCHLORIDE
NDC 43063-874, promethazine hydrochloride, tablet, from PD-Rx Pharmaceuticals, Inc..
- Product NDC
- 43063-874
- Status
- Listed
- Labeler
- PD-Rx Pharmaceuticals, Inc.
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA040712
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/43063-874 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- PROMETHAZINE HYDROCHLORIDE25 mg/1
Pharmacologic classes
Phenothiazine [EPC]; Phenothiazines [CS]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 43063-874-01 | 43063087401 | 100 TABLET in 1 BOTTLE, PLASTIC (43063-874-01) |
| 43063-874-02 | 43063087402 | 2 TABLET in 1 BOTTLE, PLASTIC (43063-874-02) |
| 43063-874-04 | 43063087404 | 4 TABLET in 1 BOTTLE, PLASTIC (43063-874-04) |
| 43063-874-05 | 43063087405 | 5 TABLET in 1 BOTTLE, PLASTIC (43063-874-05) |
| 43063-874-06 | 43063087406 | 6 TABLET in 1 BOTTLE, PLASTIC (43063-874-06) |
| 43063-874-10 | 43063087410 | 10 TABLET in 1 BOTTLE, PLASTIC (43063-874-10) |
| 43063-874-12 | 43063087412 | 12 TABLET in 1 BOTTLE, PLASTIC (43063-874-12) |
| 43063-874-15 | 43063087415 | 15 TABLET in 1 BOTTLE, PLASTIC (43063-874-15) |
| 43063-874-20 | 43063087420 | 20 TABLET in 1 BOTTLE, PLASTIC (43063-874-20) |
| 43063-874-25 | 43063087425 | 25 TABLET in 1 BOTTLE, PLASTIC (43063-874-25) |
| 43063-874-30 | 43063087430 | 30 TABLET in 1 BOTTLE, PLASTIC (43063-874-30) |
| 43063-874-79 | 43063087479 | 1 TABLET in 1 BOTTLE, PLASTIC (43063-874-79) |
| 43063-874-95 | 43063087495 | 1000 TABLET in 1 BOTTLE, PLASTIC (43063-874-95) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/5ce082e9-13eb-4e63-a9e2-657d3ef0e9f8
Use it
Look up 43063-874 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/43063-874 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 43063-874. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.